Metabolomic Analysis of Lung Cancer
The purpose of this study is to learn more about the metabolic properties of lung cancer cells.
Checked against the public recordLast updated May 9, 2022 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- University of Louisville
- Interventions being studied
- Other: 13-C-glucose
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Lung Cancer Patients (Groups 1 \& 2) Inclusion Criteria: * patients with suspected, clinically diagnosed, or histologically diagnosed lung cancer. Occasionally, other cancers (including metastatic cancers to the lung) may be resected for the study as negative controls for NSCLC, as warranted by the particulars of the case. * patients must have general medical conditions to allow them to undergo surgical resection of their primary tumor Exclusion Criteria: * history of diabetes for the experimental group (surgery + glucose); patients with a history of diabetes are allowed in the control group (surgery/no glucose) * known hepatitis C or HIV (AIDS) Healthy Subjects (Group 3) Inclusion Criteria: * at least 30 years of age * preferably be fasting for 12 hours (minimum 8 hours) prior to enrollment Exclusion Criteria: * prior history of diagnosed lung cancer * known hepatitis C or HIV (AIDS)
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- James Graham Brown Cancer Center, University of LouisvilleLouisville, Kentucky
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 9, 2022. Always confirm current availability with the study team.